References
- 대한감염학회: 항생제의 길잡이 제3판 p352.
- Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet Inf Dis. 2006;6(9):589-601. https://doi.org/10.1016/S1473-3099(06)70580-1
- Schindler M, Osborn MJ. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry 1979;18(20):4425-30. https://doi.org/10.1021/bi00587a024
- Brown JM, Dorman DC, Roy LP. Acute renal failure due to overdosage of colistin. Med J Austral 1970;2(20):923-24.
- Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit care 2006;10(1):1.
- Markou N, Apostolakos H, Koumoudiou C, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003;7(5):1.
- Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negativebacterial infections. Clin Inf Dis 2005;40(9):1333-41. https://doi.org/10.1086/429323
- Levin AS. Treatment of Acinetobacter spp. infections. Exp opin Pharmaco 2003;4(8):1289-96. https://doi.org/10.1517/14656566.4.8.1289
- Martinez-Garcia MA. Nebulized Antibiotic Therapy. Archivos de Bronconeumologia (English Edition) 2014;50(10):415-6. https://doi.org/10.1016/j.arbr.2014.03.018
- Sabuda DM, Laupland K, Pitout J, et al. Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa. Cana J Inf Dis Med Microbio 2008;19(6):413-8.
- Steinfort DP, Steinfort C. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis. Int Med J 2007;37(7):495-8. https://doi.org/10.1111/j.1445-5994.2007.01404.x
- Lu Q, Girardi C, Zhang M, et al. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Int Care Med 2010;36(7):1147-55. https://doi.org/10.1007/s00134-010-1879-4
- Lu Q, Luo R, Bodin L, et al. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. J Am Soc Anesth 2012;117(6):1335-47.
- Kwa AL, Loh C, Low JG, et al. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Inf Dis 2005;41(5): 754-7. https://doi.org/10.1086/432583
- Naesens R, Vlieghe E, Verbrugghe W, et al. A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa. BMC Inf Dise 2011;11(1):317. https://doi.org/10.1186/1471-2334-11-317
- Tumbarello M, De Pascale G, Trecarichi EM, et al. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. CHEST J 2013;144(6):1768-75. https://doi.org/10.1378/chest.13-1018
- Insert paper: SamChunDang Pharm. Co., Ltd.
- Kim DK, Joo KW, Acute Kidney Injury: Clinical Praetice Guidelinelines. Korean J Med 2015; 88(4):357-62. https://doi.org/10.3904/kjm.2015.88.4.357
- Akajagbor DS, Wilson SL, Shere-Wolfe KD, et al. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Inf Dis 2013;57(9):1300-03. https://doi.org/10.1093/cid/cit453
- DeRyke CA, Crawford AJ, Uddin N, et al. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Chemoth 2010;54(10):4503-05. https://doi.org/10.1128/AAC.01707-09
- Jain R, Danziger LH. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacoth 2004; 38(9):1449-59. https://doi.org/10.1345/aph.1D592
- Appel GB, Neu HC. The nephrotoxicity of antimicrobial agents.New Engl J Med 1977;296(13):722-8. https://doi.org/10.1056/NEJM197703312961305
- Goetz MB, Sayers J. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J Antimicro Chemoth 1993;32(2):325-4. https://doi.org/10.1093/jac/32.2.325
- Bailie GR, Neal D. Vancomycin ototoxicity and nephrotoxicity. Med Toxicol Adve Drug Expe 1988;3(5):376-386.
- Deray G. Amphotericin B nephrotoxicity. J Antimicro Chemoth 2002;49(suppl1):37-41 https://doi.org/10.1093/jac/49.suppl_1.37
- Berlana D, Llop JM, Fort E, et al. Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health-syst Pharm 2005;62(1):39-47.
- Park, S. Y., et al. Clinical Effectiveness and Nephrotoxicity of Aerosolized Colistin Treatment in Multidrug-Resistant Gram-Negative Pneumonia. Korean J Critical Care Med 2016, 31.3: 208-220. https://doi.org/10.4266/kjccm.2016.00129
- Cho, A Young et al. Comparison of Clinical Characteristics of Patients with Acute Kidney Injury after Intravenous versus Inhaled Colistin Therapy. Kidney Research and Clinical Practice 35.4 (2016):229-232. PMC. Web. 21 Apr. 2017. https://doi.org/10.1016/j.krcp.2016.07.005